FAM30A and nonpapillary renal cell carcinoma: (J-L) Overall survival time was shorter in ccRCC patients with high expression of SNHG4, LINC01232, and FAM30A than in ccRCC patients with low expression of SNHG4, LINC01232, and FAM30A based on TCGA dataset.